PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Alendronic acid
Presentation Product Chemical substance Chapter Items dispensed
Alendronic acid 70mg tablets
0606020A0AAACAC
Alendronic acid Alendronic acid Endocrine System 1,329,415
Alendronic acid 70mg effervescent tablets sugar free
0606020A0AAAHAH
Alendronic acid Alendronic acid Endocrine System 24,450
Alendronic acid 10mg tablets
0606020A0AAAAAA
Alendronic acid Alendronic acid Endocrine System 2,892
Alendronic acid 70mg/100ml soln unit dose sugar free
0606020A0AAAFAF
Alendronic acid Alendronic acid Endocrine System 2,207
Alendronic acid 35mg/5ml oral solution
0606020A0AAADAD
Alendronic acid Alendronic acid Endocrine System No data available
Alendronic acid 5mg tablets
0606020A0AAABAB
Alendronic acid Alendronic acid Endocrine System No data available
Alendronic acid 70mg/5ml oral solution
0606020A0AAAEAE
Alendronic acid Alendronic acid Endocrine System No data available
Alendronic acid 70mg/75ml oral solution unit dose
0606020A0AAAGAG
Alendronic acid Alendronic acid Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.